Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems ; volume:8 ; number:1 ; day:18 ; month:10 ; year:2018 ; pages:1-11 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.10.2018), 1-11, 12.2018
- Urheber
-
Shang, Enyuan
- Beteiligte Personen und Organisationen
-
Zhang, Yiru
Shu, Chang
Ishida, Chiaki Tsuge
Bianchetti, Elena
Westhoff, Mike-Andrew
Karpel-Massler, Georg
Siegelin, Markus D.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-33784-2
- URN
-
urn:nbn:de:101:1-2018111716203541223699
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shang, Enyuan
- Zhang, Yiru
- Shu, Chang
- Ishida, Chiaki Tsuge
- Bianchetti, Elena
- Westhoff, Mike-Andrew
- Karpel-Massler, Georg
- Siegelin, Markus D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
Epigenetic targeting of Mcl-1 Is synthetically lethal with Bcl-xL/Bcl-2 inhibition in model systems of glioblastoma
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
Epigenetic targeting of Mcl-1 Is synthetically lethal with Bcl-xL/Bcl-2 inhibition in model systems of glioblastoma
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
Inhibition of Bcl-2/Bcl-xL and c-MET causes synthetic lethality in model systems of glioblastoma
Epigenetic targeting of Mcl-1 Is synthetically lethal with Bcl-xL/Bcl-2 inhibition in model systems of glioblastoma
Bcl-XL but Not Bcl-2 is a potential target in medulloblastoma therapy
Regulation of Bcl-xL activity in apoptosis
Photodynamic therapy combined with Bcl-2/Bcl-xL inhibition increases the Noxa/Mcl-1 ratio independent of usp9X and synergistically enhances apoptosis in glioblastoma
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis
Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
Transient apoptosis inhibition by Bcl-xL overexpression during hematopoietic stem cell transplantation
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Rolle von Bcl-2, Bcl-xl und Mcl-1 für die Apoptoseresistenz und Chemoresistenz des Pankreaskarzinoms